Clinical Interests

Complex genitourinary reconstruction; clinical outcomes research; clinical trials;  urolithiasis; uro-oncology; laparoscopic-assisted; robotic-assisted surgery; vesicoureteral reflux

Research Interests

Modulation of apoptosis in cryptorchidism (undescended testes) with anti-oxidant pharmacotherapy; pediatric urologic surgical outcomes analysis using an evidence based medicine approach 

BS: Georgia Institute of Technology, Atlanta, GA, 1991.

Fulbright Fellowship: Universite' Rene' Descartes, Paris, France, 1992.

MD: University of Kentucky, Lexington, KY, 1996.

Residency: Medical University of South Carolina, Charleston, SC, 2001.

Fellowship: Cincinnati Children's Hospital, Cincinnati, OH, 2003.

MPH: Harvard University, Boston, Massachusetts, School of Public Health, 2005.

DeFoor, WR, et al. The risk of recurrent urolithiasis in children is dependent on urinary calcium and citrate. Urology. 2010 Jul;76(1):242-5.

DeFoor WR, et al. Long-Term Outcomes of the Neobladder in Pediatric Continent Urinary Reconstruction. J Urol. 2009;181:2689-94.

Traxel E, DeFoor WR, et al. Multivariate analysis of risk factors for urinary tract infections after endoscopic injection of dextranomer-hyaluronic acid. J Urol. 2009;182 (4 Suppl): 1708-12.

DeFoor WR, Tobias N. Simple behavioral modification may be effective first-line treatment in resolution of nocturnal enuresis. J Pediatrics. 2009;155(5):760.

Heshmat S, DeFoor WR, et al. The use of customized Mic-Key gastrostomy button for the management of the MACE stomal complications. Urology. 2008;72(5):1026-9.

DeFoor WR, et al. Urinary metabolic evaluations in solitary and recurrent stone forming children. J Urol. 2008;179(6):2369-72.

DeFoor WR, et al. Risk factors for end stage renal disease in children with posterior urethral valves. J Urol. 2008;180(4 Suppl):1705-8; discussion 1708.